The metabolic syndrome (MS) is associated with structural and functional alterations of the left ventricle (LV); no evidence is available on the impact of the MS on the right ventricle (RV). To assess whether MS, as defined by the ATP III report, is associated with biventricular hypertrophy, a total of 286 hypertensive subjects (mean age 58.7±12.2 years) attending our outpatient clinic underwent the following procedures: (1) physical examination and standard clinic blood pressure (BP) measurement; (2) routine laboratory investigations; (3) M-mode, two-dimensional and Doppler echocardiography. LV hypertrophy (LVH) was defined by LM mass index X51/47 g m À2.7 in men and women, respectively. Right-sided chambers were measured in parasternal long axis at the outflow tract and subcostal view; RV hypertrophy (RVH) was defined by anterior RV wall thickness X6.0/5.5 mm in men and women, respectively. Filling velocities of both ventricles were assessed by pulsed Doppler echocardiography. Structural cardiac alterations were more pronounced in hypertensive men and women with MS than in their non-MS counterparts and involved both ventricles as shown by the differences in continuous variables as well as in prevalence rates of LVH (58 and 48% vs 28 and 30%, respectively, Po0.01) and RVH (48 and 54% vs 25 and 35%, respectively, Po0.01). Both LV and RV filling in MS hypertensives were more dependent on the atrial systole. Our study shows that in human hypertension, structural and functional cardiac changes induced by MS are not limited to the LV but also involve the right one.
Introduction
A growing body of evidence indicates that the clustering of metabolic and haemodynamic abnormalities characterizing the metabolic syndrome (MS) 1 is associated with a prevalence of subclinical damage in a variety of organs, such as left ventricular (LV) hypertrophy (LVH), thickening or atherosclerotic plaques of carotid arteries, microalbuminuria and deranged renal function. [2] [3] [4] [5] [6] All these alterations have been shown to be associated with an increased risk of cardiovascular fatal and non-fatal events. [7] [8] [9] [10] [11] Among the markers of organ damage, most attention has been devoted to LVH, because of the high prevalence of this phenotype and to its proven association with increased cardiovascular risk. In human hypertension, LVH is considered a primary adaptation to the increased afterload, although non-haemodynamic factors, such as genetic, neurohormonal and metabolic stimuli, have been shown to contribute to this phenotype. 12 Echocardiographic studies in population-based samples or hypertensive cohorts show that a number of metabolic risk factors and the full expression of MS are associated with increased LV mass and LVH prevalence. These findings support the view that high-normal or frankly elevated blood pressure (BP), central obesity and metabolic risk factors have a crucial function in the pathogenesis of subclinical cardiac alterations through a synergistic effect between the hemodynamic pressure/volume overload and direct trophic stimuli on myocardial growth. 13, 14 If the relationship between MS and LV subclinical damage has been extensively documented, no studies, so far, have evaluated the impact of MS on the right cardiac sections, although it is known that increased right ventricular (RV) wall thickness often accompanies LVH in hypertension. Accordingly, purpose of this study was to determine the relation between MS and biventricular morphofunctional changes in a cohort of essential hypertensive subjects.
Materials and methods

Study population
Three hundred consecutive, treated or untreated essential hypertensive patients, most of them referred to our hypertension clinic by general practitioners during a period of 6 months between January and June 2007, were included in the study.
High BP was defined as a systolic BP (SBP) X140 mm Hg and/or diastolic BP (DBP) X90 mm Hg in untreated subjects; treated hypertensives were included regardless of BP values. Main exclusion criteria were history or evidence of congestive heart failure, atrial fibrillation, previous stroke, significant cardiac valve disease (moderate or severe valvular regurgitation, any degree of valvular stenosis or presence of prosthesis), previous myocardial infarction or coronary bypass, secondary causes of hypertension, pulmonary and neoplastic disease. After an informed consent had been obtained during the initial visit, all patients underwent the following procedures within a 1-2-week interval: medical history and physical examination, clinic BP measurement, blood and urine sampling, standard 12-lead electrocardiogram, M-mode, two-dimensional and Doppler echocardiographic examination. In all subjects, laboratory tests for secondary hypertension were performed when considered appropriate on clinical grounds. The study protocol was approved by the Ethics Committee of one of the Institutions involved.
Definition of the metabolic syndrome
The MS was diagnosed when, in addition to high BP (SBP X130 mm Hg or DBP X85 mm Hg or antihypertensive medication), a common feature of all subjects enrolled, two or more of the following criteria were present: abdominal obesity (waist circumference X102 cm in men and X88 cm in women), hypertriglyceridemia (X150 mg per 100 ml, 1.69 mmol l À1 ). or drug treatment for elevated triglycerides, reduced high-density lipoprotein cholesterol (o40 mg per 100 ml, 1.04 mmol l À1 in men and o50 mg, 1.29 mmol l À1 in women) and high fasting plasma glucose (X100 mg per 100 ml, 6.1 mmol l À1 ) or drug treatment for elevated glucose.
1 Waist circumference was measured to the nearest 0.5 cm at midpoint between the bottom of the rib cage and the top of the iliac crest.
Clinic BP measurement Blood pressure was measured by a physician during two different visits at the outpatient clinic using a mercury sphygmomanometer and taking the first and fifth phases of Koroktoff sounds to identify systolic (S) and diastolic (D) values, respectively. At each visit, three measurements were taken at 1-min interval after the subjects had rested 5 min in the sitting position; the average value was used to define clinic SBP and DBP.
Echocardiography
Left chambers. End-diastolic and end-systolic LV internal diameter, interventricular septum thickness and posterior wall thickness were measured on twodimensionally guided M-mode tracings during at least five cycles according to the Penn convention. 15 LV mass (LVM) was calculated by Devereux's formula and normalized to height 2.7 ; 16 LVH was defined by LVM index (LVMI) X51 g m À2.7 in men and 47 g m À2.7 in women. 17 Relative wall thickness (RWT) was calculated as (2 Â posterior wall thickness )/end-diastolic LV internal diameter. Patterns of abnormal LV geometry were defined according to Ganau et al. 18 as follows: (1) LV concentric remodelling by normal LVMI and RWT X0.45; (2) eccentric LVH by increased LVMI and RWT o0.45; concentric LVH by increased LVMI and RWT X0.45.
Left ventricular myocardial function was assessed as the midwall circumferential shortening and calculated by a two-shell cylindrical model, 19 this method allows a better characterization of systolic myocardial function, especially in the presence of increased RWT, compared with endocardial fractional shortening.
Left ventricular filling was assessed by recording mitral flow by standard pulsed Doppler technique in apical four-chamber view, and the following parameters were considered: early diastolic peak flow velocity (Em), late diastolic flow velocity (Am), the ratio (E/A) M and Em-wave deceleration time (from peak Em wave to baseline).
Left atrial diameter (LAD) was assessed by three measurements: LAD1 (by the parasternal long-axis view using a leading edge-to-leading edge measurement of the maximal distance between posterior aortic root wall and posterior left atrial wall at end systole), LAD2 and LAD3 (long and short axis, respectively, in apical four-chamber view at ventricular end systole).
Right chambers. Right ventricular internal enddiastolic diameter and RV end-diastolic thickness were measured on two-dimensionally guided Mmode tracings in the parasternal long-axis view (anterior wall), at the outflow tract level as well as in the subcostal view at the tips level of the tricuspid valve. RV filling was assessed by recording tricuspid flow by standard pulsed Doppler technique in apical four-chamber view and the following parameters were considered: early diastolic peak flow velocity (Et), late diastolic flow velocity (At), their ratio (E/A) T and Et-wave deceleration time (from peak Et wave to baseline). RV global systolic function was assessed as the tricuspid annular plane systolic excursion, by a two-dimensional difference of enddiastolic and end-systolic lines (in cm) traced between the centre of the ultrasound fan origin and the junction of RV lateral tricuspid annulus in apical four-chamber view.
Two right atrial diameters (RAD) were measured: RAD1 and RAD2 (long and short axis, respectively, in apical four-chamber view at ventricular endsystole).
Right ventricular hypertrophy (RVH) was defined by an RV anterior thickness X6.0 mm in men and X5.5 mm in women; these cut-points correspond to the 90th percentile in a group of 90 normotensive (clinic BP o140/90 mm Hg), non-obese, apparently normal adults evaluated in our hospital outpatient clinic for a cardiovascular check-up in the last 2 years.
Reproducibility of RV wall thickness measurement was evaluated in a subsample of 45 randomly selected patients who underwent a second echocardiographic examination within a 3-5-day interval; intraobserver coefficient of variation was 7.9% for the parasternal and 16.9% for the subcostal view, respectively.
Statistical analysis
Statistical analysis was performed by the SAS system (version 6.12; SAS Institute Inc., Cary, NC, USA). Values were expressed as means±s.d. or as percentages. Means were compared by the Student's t-test for independent samples. Analysis of categorical data was carried out with the w 2 -test or Fischer's exact test when appropriate. In a genderbased analysis differences between subjects with and without MS were tested by one-way analysis of variance. The strength of correlation between variables was tested by linear correlation analysis and multiple regression analysis. Adjustment for age, SBP/DBP, duration of hypertension and other potential confounders was carried out, wherever appropriate, by analysis of covariance and multiple regression analysis. The limit of statistical significance was set at Po0.05.
Results
Subjects having complete clinical and echocardiographic records and included in the final analysis were 286 out of 300 hypertensives. Mean age was 58.7 ± 12.2 (range 18-87) years and mean SBP and DBP were 138.8±13.5 and 87.8±9.7 mm Hg, respectively; 89.7% of the study sample were on antihypertensive treatment, 40.1% had the MS, 13.8% were smokers and 7.3% had type 2 diabetes mellitus. In the whole population, the most common component of the MS other than high BP was abdominal obesity (63.2%) followed by high fasting glucose (46.2%), hypertriglyceridemia (29.8%) and low high-density lipoprotein cholesterol (15.1%). Table 1 shows demographic and clinical characteristics of patients categorized according to gender and presence or absence of MS. Age, mean SBP/DBP and heart rate were similar in patients with MS when compared with their counterparts of the same gender without MS. As expected, a significant difference in body mass index, blood glucose, lowdensity lipoprotein and high-density lipoprotein cholesterol, triglycerides, use of lipid and glucose lowering agents was observed both in men and women with MS compared with those without MS. The frequency of angiotensin converting enzyme inhibitors or angiotensin receptor blockers, calcium antagonists and diuretics use did not differ between patients with and without MS, whereas the frequency of b-blockers use was higher in women with MS than in their counterparts without it.
Echocardiographic and Doppler left chambers analysis
As shown in Table 2 , LV internal dimensions, LV absolute and relative wall thickness, LA diameters, LVM and LVMI were significantly greater in patients of both sexes with MS than in those without it. Furthermore, when LV echocardiographic data were analysed in a categorical way, as the presence or absence of altered patterns of LV structure and geometry, the prevalence of altered patterns (LVH plus LV concentric remodelling) was approximately 2.3-and 1.9-fold higher in men and women with MS, respectively, than in their counterparts (Po0.001 for both; Figure 1 ). With regard to LV function, mid-wall shortening, a reliable index of LV systolic performance, was significantly lower in subjects with MS regardless of gender. A greater atrial contribution to LV filling was found in patients with MS with a significantly greater A velocity and a lower (E/A) M ratio with respect to subjects without the syndrome. Finally, mitral flow deceleration time was prolonged in MS patients.
Echocardiographic and Doppler right chambers analysis
The following parameters were significantly different between MS and non-MS patients: RV diastolic internal diameter, RV diastolic wall thickness, RA diameters, (E/A) T ratio and deceleration time. No significant differences were found in RV systolic function between the groups (Table 2) . Prevalence rates of RVH, according to gender-specific thresholds were significantly higher in both hypertensive men and women with MS than in their non-MS counterparts (Figure 1) .
Differences in both LV and RV structures and functions remained still statistically significant even after adjustment, by the analysis of covariance, for age, clinic SBP/DBP, duration of hypertension as well as after exclusion of patients with type 2 diabetes.
Correlation analyses
In the whole study population, significant positive correlations were observed between (1) LV diastolic diameter, interventricular septum thickness, posterior wall thickness and the corresponding RV structural variables, (2) LA and RA diameters and (3) LV and RV filling parameters (Po0.001, at least, for all); negative correlations were found between LV as well as RV wall thickness and diastolic function variables (Po0.01, at least, for all).
In multiple logistic regression analysis, MS was independently associated with LVH and RVH, after adjustment age, duration of hypertension, clinic SBP/ DBP and use of antihypertensive (odds ratio: 1.81, 95% confidence interval: 1.11-3.18; P ¼ 0.01 for LVH and odds ratio: 1.77, 95% confidence interval: 1.16-3.12, P ¼ 0.01 for RVH). When the independent contribution of each component of the MS to LV and RV structures was evaluated in a further analysis, abdominal obesity was the only independent predictor of LVH (odds ratio: 1.71 95% confidence interval: 1.19-2.97, P ¼ 0.01) and RVH (odds ratio: 1.56, 95% confidence interval: 1.15-2.81, P ¼ 0.01), respectively.
Discussion
This study is the first to describe parallel LV and RV structural and functional changes in a cohort of hypertensive patients categorized according to gender and ATP III report MS. Unlike previous studies, our sample were more suitable for the assessment of RV involvement as it was much larger and unbiased by preselection criteria for LVH. Our results provide a new piece of evidence about preclinical cardiac damage related to MS by showing that not only leftsided but also right-sided structures are affected by MS. Several aspects of our study deserve to be discussed. First, it is confirmed that alterations in LV structure and function were more frequent in patients with MS than in those without MS. Second, the novel finding of our study is that the more pronounced involvement of LV in hypertensives with MS was paralleled by an increased RV thickness and prevalence of RVH, defined according to gender-specific thresholds derived from a simple, reliable index of hypertrophy such as anterior RV thickness. Overall, these data confirm previous reports that MS superimposed to hypertension may worsen cardiac subclinical damage, 6, 20 and extend previous information by showing that the cardiac impact of the syndrome is not only limited to the ventricle under pressure overload but also involves the RV, apparently as consequence of pathogenic mechanisms other than systemic hypertension. To date, few studies simultaneously examined left-and right-sided chambers in hypertensive patients and showed that LV adaptations to high BP 
-test (for categorical variables).
Metabolic syndrome and biventricular hypertrophy C Cuspidi et al are associated with significant structural and functional alterations in the RV. In their pioneer study, Gottdiener et al. 21 assessed the prevalence of RV hypertrophy and its relation to the increased LV wall thickness in patients with LV pressure overload, because of essential hypertension in 49 patients and aortic valve stenosis in the remaining 16 pateints. They found that average RV wall thickness in both subgroups (7.0±2.0 and 6.0±2.0 mm, respectively) was significantly greater than in normotensive 27.4 ± 3.9 28.6 ± 3.9 24.9 ± 3.7 26.3 ± 3.5 0.01 RVTd (outflow) (mm) 5.5 ± 0.9 5.9 ± 0.9 5.1 ± 0.9 5.5 ± 0.9 0.01 RVDd (subcostal; mm) 31.9 ± 3.9 33. controls (4.0±1.0 mm), and RVH was present in 80% of patients with hypertension and 63% with aortic stenosis. In a study by Nunez et al. 22 including 15 healthy normotensive subjects and 35 patients with essential hypertension (15 with normal LV and 20 with echocardiographic LVH), RV wall thickness was almost doubled in hypertensives with LVH as compared with normotensives (7.0 ± 2.1 vs 3.7 ± 0.8 mm), and RV wall thickness was significantly, directly correlated with the LV one in the entire cohort. More recently, a number of studies performed in small series of subjects have shown that RV diastolic dysfunction, as assessed by conventional and tissue Doppler analysis, [23] [24] [25] as well as RV systolic dysfunction, as assessed by myocardial velocities and strain imaging, are both common conditions in uncomplicated arterial hypertension. 26 Our study, therefore, extends previous evidence to the MS setting by showing that a more pronounced involvement of left and right structures was present in hypertensive patients with the syndrome; these alterations were associated with an impaired diastolic biventricular filling as shown by a reduced mitral and tricuspid E/A ratio as well as a prolonged deceleration time. However, it should be pointed out that alterations in LV diastolic filling in MS patients were combined with a reduced midwall shortening, a reliable index of myocardial performance, whereas no association between RV filling abnormalities and RV systolic function was found, probably because of the limited sensitivity of tricuspid annular plane systolic excursion in assessing RV performance. It has been shown that the MS may affect cardiac structures either by increasing the haemodynamic load or by direct stimuli. 27 To the available evidence about cardiac abnormalities induced by the MS that are limited to LV, our data add a new piece of information by showing that (1) these disturbances also involve RV structure and function, (2) among the MS components, central obesity, as shown by multivariate analysis, and have a pivotal function. The potential mechanisms of RV involvement in systemic hypertension remain a matter of debate and a full discussion on the interdependence of ventricles is beyond the scope of this study. Briefly, the following mechanisms can be hypothesized: (1) the increased LV filling pressure is translated to the pulmonary circulation, (2) a mechanical interaction occurs between the RV and LV and (3) both ventricles are exposed to humoral stimuli, namely circulating cytokines and growth hormones, such as angiotensin II, aldosterone, catecholamines and insulin. 28 To this purpose, it should be pointed out that our subjects with and without MS were similar for age, known duration of hypertension, as well as SBP and DBP; this supports the view that the prevalence and degree of biventricular involvement was not related to the differences in pressure load or in demographic and clinical variables known to affect cardiovascular structure, but rather to synergic influence of metabolic abnormalities characterizing MS. The difference in RV involvement described in the present study is smaller than previously reported, probably due to the fact that in previous studies hypertensive and normotensive individuals or subjects with and without LVH were compared. At difference from reports indicating that subclinical organ damage induced by MS (that is, carotid atherosclerosis and LVH) is prevalent in women, 29, 30 we found that MS was associated with a similar excess of biventricular sub-clinical damage in both genders.
Limitations of the study A comprehensive assessment of RV structure and function is impaired by the complex anatomy of the right cardiac chamber. Measurements of RV wall thickness are usually overestimated and less reproducible from the subcostal view compared to the long-axis parasternal window, because of the difficult perpendicular alignment of the ultrasound beam. For this reason, we defined RV hypertrophy according to a gender-specific RV thickness threshold measured at the level of the anterior wall only. Moreover, diastolic function assessed by standard pulsed Doppler technique is a less accurate index of ventricular filling compared with measures obtained by myocardial velocities, strain and strain rate.
Conclusion
Our study adds a new piece of evidence on the adverse effect of the MS on the heart by showing that hypertensive patients with the MS have more pronounced subclinical abnormalities in LV and RV structures and functions than their gendermatched counterparts without the syndrome.
What is known about this topic K A number of echocardiographic studies conducted in population-based samples or hypertensive cohorts have shown that subjects with metabolic risk factors or with MS have a higher LV mass or higher prevalence of LVH compared with their counterparts without MS. 2, 5, 6 K Few studies examined left-and right-sided chambers in hypertensive patients and showed that LV adaptations to high BP are associated with significant structural and functional alterations in the right ventricle. 22, 23 What this study adds K This study provides a new piece of evidence about cardiac damage related to MS by showing that not only left-sided but also right-sided structures are affected by MS. K A more pronounced involvement of left and right structures (that is, biventricular hypertrophy) is present in hypertensive patients with the MS; these alterations are associated with an impaired diastolic biventricular filling.
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